Skip to main content
Clinical Trials/DRKS00011138
DRKS00011138CompletedNot Applicable

Hemodynamic and Clinical Monitoring Program During and After the MitraClip® Procedure in Patients with Secondary MR and Advanced Systolic Heart Failure - Mitraclip Conductance

niversitätsklinikum Magdeburg0 sites77 target enrollmentStarted: November 30, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
77

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • Age >18 years
  • -Systolic heart failure, EF < 25%, NYHA III/IV
  • -Severe functional mitral regurgitation according to ACC/AHA guidelines: ERO = 20 mm2, regurgitant fraction = 50%, regurgitant volume = 30ml
  • -Clinical indication for MitraClip® Implantation
  • -Cardiac index = 2.1 l/min/qm
  • -Signed written informed consent

Exclusion Criteria

  • -Myocardial infarction within the last 3 months
  • -Consuming tumor with an expected life expectancy < 12 months
  • -Impossibility of MitraClip®-Implantation
  • -Inability to follow instructions or comply with follow-up procedures, e.g. 6-minute-Walking Test
  • -Pregnancy

Investigators

Sponsor
niversitätsklinikum Magdeburg

Similar Trials